Advus Financial Partners, LLC’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Sell
2,374
-317
-12% -$109K 0.2% 92
2026
Q1
$947K Buy
2,691
+88
+3% +$31.4K 0.24% 78
2025
Q4
$852K Buy
2,603
+3
+0.1% +$952 0.21% 77
2025
Q3
$734K Sell
2,600
-72
-3% -$20.9K 0.18% 88
2025
Q2
$746K Buy
2,672
+81
+3% +$22.9K 0.19% 84
2025
Q1
$807K Buy
2,591
+146
+6% +$43.1K 0.23% 70
2024
Q4
$637K Sell
2,445
-189
-7% -$56.1K 0.18% 81
2024
Q3
$849K Sell
2,634
-35
-1% -$11.4K 0.24% 64
2024
Q2
$834K Buy
2,669
+534
+25% +$157K 0.25% 60
2024
Q1
$607K Buy
2,135
+165
+8% +$48.3K 0.19% 74
2023
Q4
$567K Buy
1,970
+51
+3% +$13.9K 0.19% 74
2023
Q3
$516K Buy
1,919
+210
+12% +$52.4K 0.2% 71
2023
Q2
$379K Sell
1,709
-454
-21% -$105K 0.15% 89
2023
Q1
$523K Buy
2,163
+194
+10% +$47.6K 0.22% 70
2022
Q4
$517K Sell
1,969
-65
-3% -$17.4K 0.23% 67
2022
Q3
$459K Buy
2,034
+56
+3% +$13.6K 0.24% 60
2022
Q2
$481K Buy
1,978
+464
+31% +$114K 0.25% 58
2022
Q1
$366K Buy
+1,514
New +$348K 0.19% 76
2021
Q3
$282K Buy
+1,254
New +$289K 0.16% 78

Other funds holding AMGN

Advus Financial Partners, LLC's AMGN Position: Q2 2026 in Review

Advus Financial Partners, LLC reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $109K and leaving 2,374 shares worth $860K. The position accounts for 0.2% of the portfolio, ranked #92.

Advus Financial Partners, LLC first reported a position in AMGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $947K in Q1 2026. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advus Financial Partners, LLC held 2,374 shares of Amgen worth $860K as of Q2 2026.
  • Advus Financial Partners, LLC sold 317 Amgen shares in Q2 2026, an estimated $109K.
  • Amgen made up 0.2% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #92 holding.
  • Advus Financial Partners, LLC first reported a position in Amgen in Q3 2021 and has held it in 19 quarters since.
  • Advus Financial Partners, LLC's Amgen position peaked at $947K in Q1 2026.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.